MAPT and Alzheimer disease: Characterized by abnormal amyloid deposition, tau phosphorylation and neurodegeneration in pathology and cognitive and behavioral impairments in clinic, Alzheimer’s disease (AD) has a prolonged asymptomatic phase in the course of the Alzheimer’s continuum before pathological biomarkers appeared [1–4].